Loading stock data…
Strata Critical Medical, Inc. (SRTA)
$5.31-0.01 (-0.19%)
Market ClosedLast close Sep 8
Strata Critical Medical, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Strata Critical Medical, Inc. in the Healthcare sector is trading at $5.31 with a market capitalization of $470M. Wall Street consensus targets $9.56 (4 analysts), implying a +80.1% move over the next 12 months. The stock is currently 18% below its 52-week high of $6.50, remaining 4.1% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +80.1% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $67.38M↑ | $66.79M↑ | $49.30M↓ | $70.80M↑ | $35.95M |
| Gross Profit | $14.12M↑ | $11.67M↑ | $11.61M↓ | $17.74M↑ | $7.05M |
| Operating Income | -$2.97M↑ | -$6.41M↓ | -$5.62M↓ | -$4.95M↑ | -$5.68M |
| Net Income | $2.15M↑ | -$8.83M↓ | $57.42M↑ | -$3.74M↓ | -$3.49M |
Peer Comparison
JNJUNHPFE
Fundamentals
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground tr...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$469.76M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.26
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
14.40%
Volume
Today's trading volume
878,901
Recent News
Strata Critical Medical, Inc. (SRTA) Upgraded to Buy: What Does It Mean for the Stock?
Strata Critical Medical, Inc. (SRTA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Does Strata Critical Medical, Inc. (SRTA) Have the Potential to Rally 47.28% as Wall Street Analysts Expect?
The mean of analysts' price targets for Strata Critical Medical, Inc. (SRTA) points to a 47.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Strata Critical Medical (SRTA) Q2 2026 Earnings Call Transcript
Clinical revenue surged 22.6% (including acquisitions) sequentially as acquisitions bolster transplant services.
Immersion Investment Views Strata Critical Medical (SRTA) as a “Babushka Doll”
Immersion Investment Partners, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Immersion Investment Partners returned 39.1% in the second quarter, surpassing the Russell 2000 Index’s 21.5% gain. The market started valuing their non-AI investments more rationally in the quarter, focusing on strong management, revenue […]
Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?
Strata Critical Medical, Inc. (SRTA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.